TransparencyOversight & ethics enforcement

Rep. Carol Miller disclosed 21 spousal stock trades from 2021 in a Sept. 2022 House filing, past the STOCK Act's 45-day deadline

Confidence: Confirmed · 2 sourcesWest Virginia · Oct 12, 2026

Subject of this story

Carol Miller, U.S. Representative, West Virginia 1st District

What happened

A House Periodic Transaction Report that Rep. Carol Miller signed on Sept. 2, 2022 lists 21 spousal stock transactions in 20 companies dated between March 4 and Nov. 10, 2021, including Johnson & Johnson, Quest Diagnostics, Gilead Sciences, General Dynamics and L3Harris, each in the $1,001 to $50,000 range. The STOCK Act requires members of Congress to report such transactions within 45 days. No Ethics Committee finding or penalty was located in the sources reviewed. Miller's other House periodic transaction reports reviewed (Jan. 2022 to 2025), including a second report signed the same day for August 2022 trades, were filed within 45 days of their transactions, and a 2026 report only amended the dollar ranges on four 2025 sales already disclosed.

Sources (2)

Clerk of the U.S. House - Periodic Transaction Report, Filing ID 20021633 (Hon. Carol Devine Miller, signed 09/02/2022)Spousal (SP) transactions dated 03/04/2021 through 11/10/2021 in Abbott, Amgen, BlackRock, Bristol-Myers Squibb, Cisco, Clorox, Dominion Energy, General Dynamics, Gilead, Hormel, Iron Mountain, Johnson & Johnson, L3Harris, Merck, Procter & Gamble, Quest Diagnostics, Texas Instruments, ViacomCBS, Viatris and Waste Management; digitally signed 09/02/2022.

Business InsiderInsider review found Miller reported her husband's trades in 21 stocks during 2021 but did not publicly disclose them until that week; communications director acknowledged a 'technical error' that 'has since been rectified.'

Response

Carol Miller

Statement given

Contacted and responded — exact wording not on record.

What happened next (0)

No outcome recorded yet.

I saw an update

Take action →